Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 47

1.

Reply to Eisen and McBryde.

Veloso TR, Que YA, Moreillon P, Entenza JM.

J Infect Dis. 2015 Mar 9. pii: jiv133. [Epub ahead of print] No abstract available.

PMID:
25754979
2.

Low C-reactive protein values at admission predict mortality in patients with severe community-acquired pneumonia caused by Streptococcus pneumoniae that require intensive care management.

Que YA, Virgini V, Lozeron ED, Paratte G, Prod'hom G, Revelly JP, Pagani JL, Charbonney E, Eggimann P.

Infection. 2015 Mar 3. [Epub ahead of print]

PMID:
25732200
3.

Impact of the introduction of real-time therapeutic drug monitoring on empirical doses of carbapenems in critically ill burn patients.

Fournier A, Eggimann P, Pagani JL, Revelly JP, Decosterd LA, Marchetti O, Pannatier A, Voirol P, Que YA.

Burns. 2015 Feb 10. pii: S0305-4179(15)00002-9. doi: 10.1016/j.burns.2015.01.001. [Epub ahead of print]

PMID:
25678084
4.

Targeting Enterococcus faecalis biofilm using phage therapy.

Khalifa L, Brosh Y, Gelman D, Coppenhagen-Glazer S, Beyth S, Poraduso-Cohen R, Que YA, Beyth N, Hazan R.

Appl Environ Microbiol. 2015 Feb 6. pii: AEM.00096-15. [Epub ahead of print]

PMID:
25662974
5.

Preventing invasive candida infections. Where could we do better?

Eggimann P, Que YA, Revelly JP, Pagani JL.

J Hosp Infect. 2014 Dec 16. pii: S0195-6701(14)00371-5. doi: 10.1016/j.jhin.2014.11.006. [Epub ahead of print]

6.

Sputum containing zinc enhances carbapenem resistance, biofilm formation and virulence of Pseudomonas aeruginosa.

Marguerettaz M, Dieppois G, Que YA, Ducret V, Zuchuat S, Perron K.

Microb Pathog. 2014 Dec;77:36-41. doi: 10.1016/j.micpath.2014.10.011. Epub 2014 Oct 22.

PMID:
25448466
7.

Effective Treatment of Invasive Aspergillus fumigatus Infection Using Combinations of Topical and Systemic Antifungals in a Severely Burned Patient.

Fournier A, Pantet O, Guerid S, Eggimann P, Pagani JL, Revelly JP, Hauser PM, Marchetti O, Fontanella S, Letovanec I, Ravat F, Berger MM, Pannatier A, Voirol P, Que YA.

J Burn Care Res. 2015 Mar-Apr;36(2):e85-9. doi: 10.1097/BCR.0000000000000143.

PMID:
25127025
8.

Prophylaxis of experimental endocarditis with antiplatelet and antithrombin agents: a role for long-term prevention of infective endocarditis in humans?

Veloso TR, Que YA, Chaouch A, Giddey M, Vouillamoz J, Rousson V, Moreillon P, Entenza JM.

J Infect Dis. 2015 Jan 1;211(1):72-9. doi: 10.1093/infdis/jiu426. Epub 2014 Aug 1.

PMID:
25086177
9.

Prediction of multiple infections after severe burn trauma: a prospective cohort study.

Yan S, Tsurumi A, Que YA, Ryan CM, Bandyopadhaya A, Morgan AA, Flaherty PJ, Tompkins RG, Rahme LG.

Ann Surg. 2015 Apr;261(4):781-92. doi: 10.1097/SLA.0000000000000759.

PMID:
24950278
10.

Assessment of panobacumab as adjunctive immunotherapy for the treatment of nosocomial Pseudomonas aeruginosa pneumonia.

Que YA, Lazar H, Wolff M, François B, Laterre PF, Mercier E, Garbino J, Pagani JL, Revelly JP, Mus E, Perez A, Tamm M, Rouby JJ, Lu Q, Chastre J, Eggimann P.

Eur J Clin Microbiol Infect Dis. 2014 Oct;33(10):1861-7. doi: 10.1007/s10096-014-2156-1. Epub 2014 May 24.

PMID:
24859907
11.

Assessing Pseudomonas aeruginosa Persister/antibiotic tolerant cells.

Hazan R, Maura D, Que YA, Rahme LG.

Methods Mol Biol. 2014;1149:699-707. doi: 10.1007/978-1-4939-0473-0_54.

PMID:
24818944
12.

Carnitine deficiency in chronic critical illness.

Bonafé L, Berger MM, Que YA, Mechanick JI.

Curr Opin Clin Nutr Metab Care. 2014 Mar;17(2):200-9. doi: 10.1097/MCO.0000000000000037. Review.

PMID:
24500444
13.

[Continuous renal replacement therapy for acute kidney injury].

Aymon L, Kissling S, Revelly JP, Que YA, Schneider AG.

Rev Med Suisse. 2013 Dec 11;9(410):2324, 2326-9. French.

PMID:
24416980
14.

A quorum sensing small volatile molecule promotes antibiotic tolerance in bacteria.

Que YA, Hazan R, Strobel B, Maura D, He J, Kesarwani M, Panopoulos P, Tsurumi A, Giddey M, Wilhelmy J, Mindrinos MN, Rahme LG.

PLoS One. 2013 Dec 19;8(12):e80140. doi: 10.1371/journal.pone.0080140. eCollection 2013.

15.
16.

Use of a human-like low-grade bacteremia model of experimental endocarditis to study the role of Staphylococcus aureus adhesins and platelet aggregation in early endocarditis.

Veloso TR, Chaouch A, Roger T, Giddey M, Vouillamoz J, Majcherczyk P, Que YA, Rousson V, Moreillon P, Entenza JM.

Infect Immun. 2013 Mar;81(3):697-703. doi: 10.1128/IAI.01030-12. Epub 2012 Dec 17.

17.

The quorum sensing volatile molecule 2-amino acetophenon modulates host immune responses in a manner that promotes life with unwanted guests.

Bandyopadhaya A, Kesarwani M, Que YA, He J, Padfield K, Tompkins R, Rahme LG.

PLoS Pathog. 2012;8(11):e1003024. doi: 10.1371/journal.ppat.1003024. Epub 2012 Nov 15.

18.

A method for high throughput determination of viable bacteria cell counts in 96-well plates.

Hazan R, Que YA, Maura D, Rahme LG.

BMC Microbiol. 2012 Nov 13;12:259. doi: 10.1186/1471-2180-12-259.

19.

Pancreatic stone protein as an early biomarker predicting mortality in a prospective cohort of patients with sepsis requiring ICU management.

Que YA, Delodder F, Guessous I, Graf R, Bain M, Calandra T, Liaudet L, Eggimann P.

Crit Care. 2012 Jul 2;16(4):R114. doi: 10.1186/cc11406.

20.

[Usefulness of biomarkers of sepsis in the ICU].

Jolivet P, Christen G, Seematter G, Que YA, Eggimann P.

Rev Med Suisse. 2011 Dec 14;7(321):2430-4. Review. French.

PMID:
22279860
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk